» Articles » PMID: 37571424

Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases

Overview
Journal Nutrients
Date 2023 Aug 12
PMID 37571424
Authors
Affiliations
Soon will be listed here.
Abstract

Liver diseases are the major predisposing conditions for the development of malnutrition, sarcopenia, and frailty. Recently, the mechanism of the onset of these complications has been better established. Regardless of the etiology of the underlying liver disease, the clinical manifestations are common. The main consequences are impaired dietary intake, altered macro- and micronutrient metabolism, energy metabolism disturbances, an increase in energy expenditure, nutrient malabsorption, sarcopenia, frailty, and osteopathy. These complications have direct effects on clinical outcomes, survival, and quality of life. The nutritional status should be assessed systematically and periodically during follow-up in these patients. Maintaining and preserving an adequate nutritional status is crucial and should be a mainstay of treatment. Although general nutritional interventions have been established, special considerations are needed in specific settings such as decompensated cirrhosis, alcohol-related liver disease, and metabolic-dysfunction-associated fatty liver disease. In this review, we summarize the physiopathology and factors that impact the nutritional status of liver disease. We review how to assess malnutrition and sarcopenia and how to prevent and manage these complications in this setting.

Citing Articles

Screening and assessment of malnutrition in patients with liver cirrhosis.

He Y, Wang Z, Wu S, Li L, Li J, Zhang Y Front Nutr. 2024; 11:1398690.

PMID: 39091687 PMC: 11292113. DOI: 10.3389/fnut.2024.1398690.


Influence of subcutaneous adipose tissue index on prognosis in cirrhotic patients following endoscopic therapy: a retrospective cohort study.

Liu Y, Chang H, Zeng Y, Li J, Li Y, Chen Y Lipids Health Dis. 2024; 23(1):7.

PMID: 38185678 PMC: 10773050. DOI: 10.1186/s12944-023-01996-9.

References
1.
Kowdley K, Emond M, Sadowski J, KAPLAN M . Plasma vitamin K1 level is decreased in primary biliary cirrhosis. Am J Gastroenterol. 1997; 92(11):2059-61. View

2.
Topan M, Sporea I, Danila M, Popescu A, Ghiuchici A, Lupusoru R . Comparison of Different Nutritional Assessment Tools in Detecting Malnutrition and Sarcopenia among Cirrhotic Patients. Diagnostics (Basel). 2022; 12(4). PMC: 9032007. DOI: 10.3390/diagnostics12040893. View

3.
Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L . Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr. 2011; 93(4):799-808. DOI: 10.3945/ajcn.110.007393. View

4.
Wahren J, Denis J, Desurmont P, Eriksson L, Escoffier J, GAUTHIER A . Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology. 1983; 3(4):475-80. DOI: 10.1002/hep.1840030402. View

5.
Zhao V, Ziegler T . Nutrition support in end-stage liver disease. Crit Care Nurs Clin North Am. 2010; 22(3):369-80. DOI: 10.1016/j.ccell.2010.02.003. View